Shim SH, Yang EJ, Jang EB, Lee S, et al. Prognostic impact of erythropoietin-stimulating agent use during front-line chemotherapy in patients with ovarian cancer: A Korean multicenter cohort study. Int J Gynaecol Obstet 2024 Apr 29. doi: 10.1002/ijgo.15533.
PMID: 38682391